Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2825 of 3173 entries
View as:

Risk of Cancer Among Pantoprazole Users

Phase: N/A Priority: Normal
NCT ID: NCT01322633 Org: User:
Start: 07/31/04 End: 03/31/13 Due: 03/31/14

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00143364 Org: User:
Start: 06/30/03 End: 03/31/05 Due: 03/31/06

A Study to Evaluate Infants With Potential Exposure to Tanezumab Before Birth

Phase: N/A Priority: Normal
NCT ID: NCT01362660 Org: User:
Start: 06/30/11 End: 06/30/12 Due: 06/30/13

Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01100034 Org: User:
Start: 11/19/10 End: 09/24/18 Due: 09/24/19

Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02100527 Org: User:
Start: 04/30/14 End: 10/31/14 Due: 10/31/15

A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05960032 Org: User:
Start: 10/23/23 End: 12/12/23 Due: 12/12/24

Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -

Phase: N/A Priority: Normal
NCT ID: NCT01793688 Org: User:
Start: 03/12/13 End: 01/27/16 Due: 01/27/17

A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

Phase: N/A Priority: Normal
NCT ID: NCT04424316 Org: User:
Start: 06/17/20 End: 10/27/23 Due: 10/27/24

Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00862888 Org: User:
Start: 07/31/07 End: 02/29/08 Due: 02/28/09

A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population

Phase: N/A Priority: Normal
NCT ID: NCT00930722 Org: User:
Start: 06/30/09 End: 06/30/10 Due: 06/30/11

Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00311311 Org: User:
Start: 04/30/06 End: 01/31/12 Due: 01/31/13

A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone

Phase: N/A Priority: Normal
NCT ID: NCT00545129 Org: User:
Start: 04/29/09 End: 02/07/12 Due: 02/07/13

A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT01298518 Org: User:
Start: 02/28/11 End: 05/31/11 Due: 05/31/12

Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)

Phase: N/A Priority: Normal
NCT ID: NCT01311505 Org: User:
Start: 04/30/11 End: 05/31/11 Due: 05/31/12

A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05371652 Org: User:
Start: 05/19/22 End: 02/06/24 Due: 02/06/25

A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02129205 Org: User:
Start: 06/30/14 End: 07/31/17 Due: 07/31/18

A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02444793 Org: User:
Start: 05/31/15 End: 10/31/17 Due: 10/31/18

A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04498403 Org: User:
Start: 09/14/20 End: 12/18/20 Due: 12/18/21

Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT04801329 Org: User:
Start: 06/29/21 End: 03/30/30 Due: 03/30/31

STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY

Phase: N/A Priority: Normal
NCT ID: NCT04616339 Org: User:
Start: 11/04/20 End: 07/19/21 Due: 07/19/22

A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT04645966 Org: User:
Start: 11/26/20 End: 09/15/22 Due: 09/15/23

Food Effect Study for PF-06372865

Phase: N/A Priority: Normal
NCT ID: NCT02217787 Org: User:
Start: 09/30/14 End: 09/30/14 Due: 09/30/15

Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT01660334 Org: User:
Start: 07/31/06 End: 05/31/12 Due: 05/31/13

A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma

Phase: N/A Priority: Normal
NCT ID: NCT06205407 Org: User:
Start: 12/26/23 End: 03/01/24 Due: 03/01/25

Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

Phase: N/A Priority: Normal
NCT ID: NCT00472836 Org: User:
Start: 06/30/07 End: 10/31/08 Due: 10/31/09